Cite
HARVARD Citation
la Fauci, F. et al. (n.d.). Evaluation of effect on dose due to displacement of bowel and target volume in SBRT treatment for oligorecurrent crastation sensitive prostate cancer patients. Physica medica. pp. S199-. [Online].